Screener/Healthcare/Biotechnology

AVTX

Avalo Therapeutics, Inc.NASDAQ
$13.51-0.02 (-0.15%)
Micro CapUnder $20Healthcare
$3.39
$20.72
$13.15
$14.78
EPS (TTM)$-3.64
P/E Ratio—
Dividend Yield—
Market Cap$195.4M
Volume841K
Prev Close$13.50
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$0-$30.6M$-2.19——
Q2 '25$0-$20.8M$-1.92——
Q1 '25$0-$13.1M$-1.25——
Q4 '24$192K-$35.3M$1.72—-18405.7%
Q3 '24$249K$23.0M$-2.83386.7%9251.8%
Q2 '24$0$98.5M$-14.07——
Q1 '24$0-$121.3M$-141.00——
Q4 '23$571K-$8.2M$-113.04138.7%-1430.5%
Get Your Daily Market Recap